-
1
-
-
11344290404
-
-
Chinese source
-
Chinese source. 2003, 7(21): 2981
-
(2003)
, vol.7
, Issue.21
, pp. 2981
-
-
-
2
-
-
11344283363
-
-
Chinese source
-
Chinese source. 1997: 188
-
(1997)
, pp. 188
-
-
-
3
-
-
11344269427
-
-
Chinese source
-
Chinese source. 1998: 251
-
(1998)
, pp. 251
-
-
-
4
-
-
11344265973
-
-
Chinese source
-
Chinese source. 2003, 7(9): 1399
-
(2003)
, vol.7
, Issue.9
, pp. 1399
-
-
-
5
-
-
0033628745
-
Selective estrogen receptor modulators and postmenopausal health
-
Roe EB, Chiu KM, Arnaud CD. Selective estrogen receptor modulators and postmenopausal health. Adv Intern Med 2000; 45: 259-78
-
(2000)
Adv. Intern. Med.
, vol.45
, pp. 259-278
-
-
Roe, E.B.1
Chiu, K.M.2
Arnaud, C.D.3
-
6
-
-
18544381541
-
Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis.; Four-year results from a randomized clinical trial
-
Delmas PD, Ensrud KE, Adachi JD, et al. Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis.; four-year results from a randomized clinical trial. J Clin Endocrinol Metab 2002; 87(8): 3609 -17
-
(2002)
J. Clin. Endocrinol. Metab.
, vol.87
, Issue.8
, pp. 3609-3617
-
-
Delmas, P.D.1
Ensrud, K.E.2
Adachi, J.D.3
-
7
-
-
0035806596
-
Evaluation of decision rules for referring women for bone densitometry by dual-energy x-ray absorptiometry
-
Cadarette SM, Jaglal SB, Murray TM, et al. Evaluation of decision rules for referring women for bone densitometry by dual-energy x-ray absorptiometry. JAMA 2001; 286(1): 57-63
-
(2001)
JAMA
, vol.286
, Issue.1
, pp. 57-63
-
-
Cadarette, S.M.1
Jaglal, S.B.2
Murray, T.M.3
-
8
-
-
0037016032
-
Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial
-
Greenspan SL, Emkey RD, Bone HG, et al. Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2002; 137(11): 875-83
-
(2002)
Ann. Intern. Med.
, vol.137
, Issue.11
, pp. 875-883
-
-
Greenspan, S.L.1
Emkey, R.D.2
Bone, H.G.3
-
9
-
-
11344250694
-
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial
-
Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA 2000; 283(17): 2236-7
-
(2000)
JAMA
, vol.283
, Issue.17
, pp. 2236-2237
-
-
Ettinger, B.1
Black, D.M.2
Mitlak, B.H.3
-
10
-
-
11344269974
-
-
Chinese source
-
Chinese source. 1998: 381
-
(1998)
, pp. 381
-
-
-
11
-
-
11344292888
-
-
Chinese source
-
Chinese source. 2003, 7(1): 76
-
(2003)
, vol.7
, Issue.1
, pp. 76
-
-
-
12
-
-
0033037272
-
A Japanese herbal medicine, Chujo-to, has a beneficial effect on osteoporosis in rats
-
Hidaka S, Okamoto Y, Yamada Y, et al. A Japanese herbal medicine, Chujo-to, has a beneficial effect on osteoporosis in rats. Phytother Res 1999; 13(1): 14-9
-
(1999)
Phytother. Res.
, vol.13
, Issue.1
, pp. 14-19
-
-
Hidaka, S.1
Okamoto, Y.2
Yamada, Y.3
-
13
-
-
0036653633
-
Bone-protecting effect of safflower seeds in ovariectomized rats
-
Kim HJ, Bae YC, Park RW, et al. Bone-protecting effect of safflower seeds in ovariectomized rats. Calcif Tissue Int 2002; 71(1): 88-94
-
(2002)
Calcif. Tissue Int.
, vol.71
, Issue.1
, pp. 88-94
-
-
Kim, H.J.1
Bae, Y.C.2
Park, R.W.3
|